Zhiyong, Ji,
Yeping, Ling,
Pingbo, Chen,
Meng, Yuxiao,
Xu, Shancai,
Wu, Pei,
Wang, Chunlei,
Ilyasova, Tatiana,
Sun, Bowen,
Shi, Huaizhang (2023) of recurrent
serious ischemic events despite standard
medical therapy, has been clinically
challenging. A
.9: coronavirus infection) took part in a clinical study at the Covid Hospital of the Bashkir State
Medical clinical study on the basis of the dental office in the
medical unit No. 1 of the
medical and sanitary unit
on the dental office of the
medical unit No. 1 of the
medical and sanitary unit of the Ministry of Internal
Tyurin, Anton V.,
Akhiyarova, Karina E.,
Valishin, Damir A.,
Sadretdinova, Lidiya D.,
Khusainova, Leonora N.,
Zagidullin, Naufal S.,
Gantseva, Khalida K.,
Pavlov, Valentin N. (2022) with COVID-19 at the Clinic of the Bashkir State
Medical University. Material and methods — We conducted
years, study design,
medical conditions, involved drugs, outcome measure, and subject information were
negative emotional
states in
medical professionals. It has been proved that our
original method
NAZAROVA, L.SH.,
DANILKO, K.V.,
MALIEVSKY, V.A.,
KARIMOV, D.O.,
BAKIROV, A.B.,
VIKTOROVA, T.V. (2020) on
medication (Wallace et al., 2011)-as the sufficient response (otherwise, as the insufficient). Genotyping
achieving clinical remission on
medication - as the sufficient response (otherwise - as the insufficient